ALDA, José A. et al. Expert Recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD). Actas Españolas de Psiquiatría, [S. l.], v. 42, n. Suppl. 1, p. 1–16, 2014. Disponível em: https://actaspsiquiatria.es/index.php/actas/article/view/1368. Acesso em: 21 jul. 2024.